Table 1

Frequencies of CT and NG diagnoses by body location and sample type

Self-samplesHC samplesAgreementKappa (κ)P value*
Nn (%)Nn (%)
Vaginal2020
 CT5 (25.0)6 (30.0)95.0%0.880.317
 NG1 (5.0)2 (10.0)95.0%0.640.317
Pharyngeal5050
 CT3 (6.0)1 (2.0)92.0%−0.030.317
 NG9 (18.0)9 (18.0)92.0%0.731.000
Rectal7373
 CT13 (17.8)14 (19.2)93.2%0.770.655
 NG22 (30.1)19 (26.0)95.9%0.900.083
Urine/urethral4343
 CT9 (20.9)10 (23.3)97.7%0.930.317
 NG16 (37.2)14 (32.6)95.4%0.900.157
Total186186
 CT30 (16.1)31 (16.7)94.1%0.780.763
 NG48 (25.8)44 (23.7)94.6%0.860.206
  • *Calculated using the McNemar’s statistical test for paired nominal data.

  • CT, Chlamydia trachomatis; HC samples, healthcare professional-collected samples; NG, Neisseria gonorrhoeae.